» Articles » PMID: 22170314

Determination of Human Anticytokine Autoantibody Profiles Using a Particle-based Approach

Overview
Journal J Clin Immunol
Publisher Springer
Date 2011 Dec 16
PMID 22170314
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anticytokine autoantibodies cause numerous human diseases, ranging from pure red cell aplasia to acquired immunodeficiencies. Rapid, simple, and affordable detection and monitoring of these antibodies is essential. We sought to develop a standardizable assay that is rapid, sensitive, and specific and able to simultaneously detect multiple anticytokine autoantibodies in small volumes (<10 μl).

Methods: We conjugated purified human cytokines to commercially available fluorescently labeled microspheres and tested them against sera from well-characterized subjects with at least one high-titer, disease-associated anticytokine autoantibody.

Results: Cytokine-conjugated microspheres efficiently and rapidly determined plasma concentration and IgG subclass of anticytokine autoantibodies in single or multiplex formats.

Conclusion: This particle-based multiplex assay can reproducibly characterize anticytokine autoantibodies. This efficient and inexpensive approach to diagnosing and monitoring anticytokine autoantibodies has clinical applications.

Citing Articles

Disseminated tuberculosis, CMV viraemia & haemophagocytic-lymphohistiocystosis syndrome in an adult patient with anti- IFNγ autoantibodies - case report and brief review.

Butel-Simoes G, Kiss C, Kong K, Rosen L, Hosking L, Barnes S Clin Immunol Commun. 2023; 4:55-59.

PMID: 37906631 PMC: 10600947. DOI: 10.1016/j.clicom.2023.08.001.


Autoantibodies to Interferons in Infectious Diseases.

Quiros-Roldan E, Sottini A, Signorini S, Serana F, Tiecco G, Imberti L Viruses. 2023; 15(5).

PMID: 37243300 PMC: 10223187. DOI: 10.3390/v15051215.


Diagnostic Accuracy of Methods for Detection of Antibodies against Type I Interferons in Patients with Endocrine Disorders.

Nuralieva N, Yukina M, Sozaeva L, Donnikov M, Kovalenko L, Troshina E J Pers Med. 2022; 12(12).

PMID: 36556169 PMC: 9783777. DOI: 10.3390/jpm12121948.


Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis.

Salvator H, Cheng A, Rosen L, Williamson P, Bennett J, Kashyap A Respir Res. 2022; 23(1):280.

PMID: 36221098 PMC: 9552154. DOI: 10.1186/s12931-022-02103-9.


Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.

Green D, Ning F, Duemler A, Myers T, Trewhitt K, Ekwede I Clin Cancer Res. 2022; 29(2):349-363.

PMID: 36099324 PMC: 9851980. DOI: 10.1158/1078-0432.CCR-22-1893.


References
1.
Lindberg C, Bokarewa M . Rituximab for severe myasthenia gravis--experience from five patients. Acta Neurol Scand. 2010; 122(4):225-8. DOI: 10.1111/j.1600-0404.2010.01345.x. View

2.
Zheng Z, Luo Y, McMaster G . Sensitive and quantitative measurement of gene expression directly from a small amount of whole blood. Clin Chem. 2006; 52(7):1294-302. DOI: 10.1373/clinchem.2005.065078. View

3.
Remmers E, Cosan F, Kirino Y, Ombrello M, Abaci N, Satorius C . Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat Genet. 2010; 42(8):698-702. PMC: 2923807. DOI: 10.1038/ng.625. View

4.
Behler C, Terrault N, Etzell J, Damon L . Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report. J Med Case Rep. 2009; 3:7335. PMC: 2737792. DOI: 10.4076/1752-1947-3-7335. View

5.
Kavuru M, Malur A, Marshall I, Barna B, Meziane M, Huizar I . An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J. 2011; 38(6):1361-7. PMC: 3874725. DOI: 10.1183/09031936.00197710. View